Top Story

New blog to address AMD prevention

October 1, 2014

Blue light is the hot “new” topic in eye care, and I get to blog about it, cool! To be clear, blue light is just the tip of the iceberg of a much broader field that includes visual performance, age-related macular degeneration and general well-being. 

I have developed a great passion for discussing these topics with colleagues and patients alike. Before we jump in, please indulge me to present a little of my history in practice. I am just an everyday, in-the-trenches practitioner like many of you reading this, so if you have been in practice awhile, you may relate.

In the Journals

Blue light–filtering IOLs effective as protection for AMD patients, study shows

October 1, 2014
Patients with dry age-related macular degeneration may benefit from blue-light filtering intraocular lenses after cataract surgery, according to a study recently…
figure Meeting News CoverageVideo

MicroPulse laser treatments efficacious in treating DME

September 27, 2014
LONDON – The subthreshold MicroPulse laser is a viable option for treating diabetic macular edema, especially in patients with initial thickening of the central…
In the JournalsPerspective

Bleb revision for hypotony maculopathy improves visual acuity, IOP

September 23, 2014
Surgical bleb revision for hypotony maculopathy significantly increased IOP and improved visual acuity for up to 1 year, according to study findings.The retrospective…
CME
figure

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
figure

MicroPulse laser treatments efficacious in treating DME

September 27, 2014
LONDON – The subthreshold MicroPulse laser is a viable option for treating diabetic macular edema, especially in…
More »

Filter By:

New blog to address AMD prevention

October 1, 2014
Blue light is the hot “new” topic in eye care, and I get to blog about it, cool! To be clear, blue light is just the tip of the iceberg…
In the Journals

Blue light–filtering IOLs effective as protection for AMD patients, study shows

October 1, 2014
Patients with dry age-related macular degeneration may benefit from blue-light filtering intraocular lenses after cataract surgery, according to a…
figure Meeting News Coverage Video

MicroPulse laser treatments efficacious in treating DME

September 27, 2014
LONDON – The subthreshold MicroPulse laser is a viable option for treating diabetic macular edema, especially in patients with initial…
In the Journals Perspective

Bleb revision for hypotony maculopathy improves visual acuity, IOP

September 23, 2014
Surgical bleb revision for hypotony maculopathy significantly increased IOP and improved visual acuity for up to 1 year, according to study…
Meeting News Coverage

Optovue launches 'entry level' OCT

September 22, 2014
LAS VEGAS – Optovue unveiled its new iScan optical coherence tomographer here at Vision Expo West.The company’s iWellness software is…
figure Meeting News Coverage

Kreissig Award Lecture highlights AMD research milestones

September 17, 2014
LONDON — The 2014 Kreissig Award was presented to Johanna M. Seddon, MD, ScM, at the Euretina meeting here for her key contributions to…
figure Meeting News Coverage

SAKURA 1 study meets primary endpoint for treatment of noninfectious uveitis

September 15, 2014
LONDON — A study of intravitreal sirolimus for the treatment of noninfectious uveitis has achieved its primary endpoint, a speaker said here…
figure Meeting News Coverage

Retinal atrophy raises concern about long-term anti-VEGF treatment, overdosing

September 14, 2014
LONDON – Anti-VEGF currently remains the best option for preserving vision in AMD patients, but might as a side effect, accelerate atrophy…
figure Meeting News Coverage

LUCAS study shows equivalence between anti-VEGF drugs following inject-and-extend regimen

September 14, 2014
LONDON – A prospective study comparing the safety and efficacy of anti-VEGF treatment for age-related macular degeneration with ranibizumab and…
figure Meeting News Coverage

Direct-to-consumer genetic tests for AMD risk assessment far from reliable

September 13, 2014
LONDON — Direct-to-consumer genetic tests for age-related macular degeneration, currently widely available via the Internet, cannot provide…
More Headlines »